Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China
Guangzhou, Guangdong, 510515, China
NCT Number: NCT07745153
1. Research Background The background of this study centers on stereotactic body radiation therapy (SBRT), an advanced form of radiotherapy that is short in duration, highly effective, and easy for patients to comply with. However, even small breathing movements can reduce its precision. Abdominal compression devices have been proven to reduce respiratory motion and are now widely used in clinical practice. This study aims to determine whether a novel abdominal compression positioning technique can control tumor motion as effectively as current abdominal compression devices, whether it works better than traditional thermoplastic masks, and whether it can offer meaningful benefits to patients undergoing radiotherapy. These questions remain to be explored. 2. Study Objectives The purpose of this study is to investigate how different immobilization devices affect the respiratory motion of liver tumors, in order to better assist with target delineation and the delivery of stereotactic body radiation therapy.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Guangzhou, Guangdong, 510515, China
This study is a single-center, ambidirectional observational study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Age ≥ 18 years.
Patients who require radiotherapy for liver cancer, as determined by the treating physician.
Life expectancy > 3 months.
Exclusion criteria
Presence of serious complications or comorbidities that may affect safety.
Time frame: Within 1 week after completion of radiotherapy
Tumor respiratory motion amplitude
Time frame: Within 1 week after completion of radiotherapy
Liver respiratory motion amplitude
Time frame: Within one year after the completion of radiotherapy
Status of local tumor control
Southern Medical University, China
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04962958
Adenocarcinoma, Antimetabolites
Guangzhou, Guangdong, China
View Trial DetailsNCT02312817
Adenocarcinoma, Carcinoma
Dallas, Texas, United States
View Trial DetailsNCT04618367
Adenocarcinoma, Carcinoma
Guangzhou, Guangdong, China
View Trial DetailsNCT05225207
Adenocarcinoma, Carcinoma
Cheonan, Chungcheongnam-do, South Korea
View Trial Details